MedPage Today on MSN6d
Deciding Whether Multiple Sclerosis Treatment Should Be DiscontinuedObservational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...
Dr Pavan Bhargava shares AAN 2025 highlights, including anticipated presentations, quick takeaways, and insights into how new ...
Dr Pavan Bhargava anticipates updates on diagnostic criteria, MRI techniques, biomarkers, treatments, and the role of diet in ...
A Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS has dosed the first patients enrolled at Yale MS ...
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosisIf approved, tolebrutinib would be ...
Nearly 50% of MS patients report pronounced fatigue, which has a significantly negative impact on their well-being, a Finnish ...
Paris: A French study has revealed that taking vitamin D3 (cholecalciferol) orally at a dose of 100,000 international units ...
Gabryelle “Gabby” Scholfield, a 16-year-old student-athlete at Edmondson Westside High School in Baltimore, who plays center ...
In her candid revelation on the podcast 'MeSsy,' actress Christina Applegate opened up about her harrowing journey with multiple sclerosis (MS), shedding light on the reality of living with this ...
New findings reveal Black Americans face higher multiple sclerosis, ms rates and mortality while being systematically ...
Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...
The trial aims to evaluate the antibody’s efficacy in treating non-active secondary progressive multiple sclerosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback